NCT03271255 2019-01-23Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)Shenzhen People's HospitalPhase 2 Unknown80 enrolled
NCT03303495 2017-10-06A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRCSun Yat-sen UniversityPhase 3 Unknown280 enrolled